Table 3 Hazard ratios (95% confidence intervals) for the association of the new-onset renal function decline with MetS defined by three types of definitions.

From: Enhanced prediction of renal function decline by replacing waist circumference with “A Body Shape Index (ABSI)” in diagnosing metabolic syndrome: a retrospective cohort study in Japan

Variables

Japanese WC-MetS

Japanese ABSI-MetS

IDF WC-MetS

IDF ABSI-MetS

NCEP-ATPIII WC-MetS

NCEP-ATPIII ABSI-MetS

Male

1st analysis

0.665 (0.419–1.056)

1.859 (1.266–2.730)*

1.092 (0.793–1.505)

1.598 (1.069–2.390)*

0.729 (0.390–1.365)

1.269 (0.858–1.878)

 

2nd analysis

0.697 (0.440–1.102)

1.534 (1.038–2.265)*

0.943 (0.684–1.302)

1.254 (0.834–1.886)

0.664 (0.357–1.237)

1.043 (0.704–1.546)

Female

1st analysis

0.756 (0.368–1.553)

1.611 (1.172–2.214)*

0.782 (0.562–1.087)

1.147 (0.833–1.579)

0.829 (0.508–1.355)

1.083 (0.786–1.492)

 

2nd analysis

0.881 (0.430–1.805)

1.463 (1.063–2.014)*

0.728 (0.523–1.014)

1.026 (0.745–1.414)

0.828 (0.549–1.250)

0.985 (0.715) (1.356)

  1. *p < 0.05, Cox-proportional hazards analyses. Renal function decline is defined as eGFR <60 mL/min/1.73 m2 during the 4-year study period.
  2. The hazard ratios for each MetS are expressed after adjustment for the following confounders;
  3. 1st analysis: adjusting for age (every 1 y), proteinuria, and receiving treatments for diabetes, hypertension and dyslipidemia.
  4. 2nd analysis: adjusting for confounders using in Model 1 and CAVI ≥ 9.0.
  5. WC-MetS, conventional metabolic syndrome (MetS) diagnosed using waist circumference (WC); ABSI-MetS, MetS diagnosed using a body shape index (ABSI) instead of WC; Japanese, criteria developed by the Japanese Committee for the Diagnostic Criteria of MetS; IDF, International Diabetes Federation; NCEP-ATPIII; National Cholesterol Education Program Adult Treatment Panel III.
Back to article page